As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

As Medicare announced a fresh set of drugs selected for its price-setting process on Friday under the Inflation Reduction Act ...

An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

The Federal Trade Commission published a second interim staff report this week on the prescription drug middleman industry, which ...

The Massachusetts Democrat is working with a Missouri Republican, and House members from each party, to press the FTC to ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...